More on ATYR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (2.2 Score)

Upcoming Events

- Earnings (8/13/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

aTyr Pharma (NQ:ATYR)
Delayed: 0.82 -0.08 (8.89%)
Prev. Close $0.90  
Open$0.87 
52 Wk High$ 
52 Wk Low$ 
Day High$0.89 
Day Low$0.82 
P/E N/A  
EPS$ 
Volume1,754,563 

Friends, Peers and Foes (?): ABBV, ARVN, ASND, BBIO, BCAX (more...)

Mar 6, 2026 12:19 PM Jefferies Reiterates Buy Rating on aTyr Pharma (ATYR): "view an immediate approval of EFZO‑FIT as low probability"
Mar 6, 2026 08:31 AM H.C. Wainwright Reiterates Neutral Rating on aTyr Pharma (ATYR): "viewing the upcoming 1Q26 Type C meeting with the FDA as a critical catalyst"
Mar 5, 2026 04:12 PM Form 10-K aTYR PHARMA INC For: Dec 31
Mar 5, 2026 04:04 PM Form 8-K aTYR PHARMA INC For: Mar 05
Mar 5, 2026 04:01 PM aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update
Feb 20, 2026 04:01 PM aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 18, 2026 08:01 AM aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
Feb 4, 2026 07:17 PM Form 4 aTYR PHARMA INC For: Feb 03 Filed by: Shukla Sanjay
Feb 4, 2026 07:15 PM Form 4 aTYR PHARMA INC For: Feb 03 Filed by: Broadfoot Jill Marie
Feb 4, 2026 07:13 PM Form 4 aTYR PHARMA INC For: Feb 03 Filed by: DENYES NANCY
View All Articles

Entities mentioned with ATYR

View All Entities